Oncology CME

The BoardVitals Hematology and Oncology CME Review offers clinicians 27 AMA PRA Category 1 Credits^TM, 27 ABIM MOC points, and over 500 Hematology and Oncology board review questions. The questions cover key topics including Breast Cancer, Gynecologic Cancer, and Transfusion Medicine. This question bank will assist clinicians with Hematology and Oncology certification and recertification.

The BoardVitals Hematology and Oncology CME Review also features:

• Quick and Convenient CME
• Computer, phone, and tablet access
• Constantly updated up-to-date questions
• Questions that are targeted specifically to the exam
• Online CME tracker
• 100% Pass Guarantee
• Statistical comparison to other Hematology and Oncology test-takers (Nationally)

After completing this activity, you should be able to:

• Make a diagnosis
• Order and interpret results
• Assess risk, determine prognosis, and apply principles from epidemiologic studies
• Describe the underlying pathophysiology of disease and basic science knowledge

Target Audience: Hematologists and Oncologists

Expert Advice and Insightful Commentary

The MKSAP® 19 Audio Companion sheds light on the latest diagnostic approaches, management strategies, and treatment guidelines. In this comprehensive audio CME program, you’ll join host Donald L. Deye, MD, FACP, as he leads lively discussions with esteemed colleagues in 11 internal medicine subspecialties. Listen as experienced clinicians from some of the world’s finest medical institutions share patient stories, insightful views of recent clinical advances, and more.

Anytime, Anywhere Audio CME

With the MKSAP 19 Audio Companion, you get:

• All-new advice and commentary — a reliable, and entertaining way to learn current oncology trends, the latest approaches to diabetes treatment, COVID updates, new tactics for managing patients with COPD, and so much more
• An easy way to prep for your ABIM certification or MOC exam
• Flexible learning to fit your schedule — in your car, between appointments, while you work out
• Companion booklets — high-impact PDF learning aids to quickly review and retain key points (print booklets available for an additional charge)
• The opportunity to earn AMA PRA Category 1 Credits™ and ABIM MOC points
• Four FREE sets of extension questions — a $350 value that brings you incremental AMA PRA Category 1 Credits™ and MOC points

Audience

General internists and primary care physicians; subspecialists who need to remain up to date in internal medicine; residents preparing for the certifying examination in internal medicine; physicians preparing for the recertification examination. 

Learning Objectives

• Discuss the most clinically relevant patient care information in all subspecialties of Internal Medicine based on the medical literature of the last 3 to 5 years
• Describe clinical situations in which this new knowledge will improve the quality of care
• Diagnose disease states that are less common and sometimes overlooked and confusing
• Determine when to refer patients for surgery or care by subspecialists

Maximize your CME allowance with MDCalc and get up to a $3,500 bonus gift card of your choice. Earn AMA PRA Category 1 Credits^TM for clinical content on 150+ calculators across multiple medical specialties. Easily earn and redeem CME at the point-of-care, online on our website or mobile app. Over 1 million medical professionals use MDCalc’s 550+ tools daily to support clinical decision making at the bedside.

Includes eleven online, self-learning activities:

• The state of prostate cancer treatment: advances in approach for advanced disease –  (1 hr CE) ACCME ACPE MOC
• Ongoing challenges and optimal approaches in the management of metastatic colorectal cancer (mCRC) – (1 hr CE) ACCME ACPE MOC
• Advanced systemic mastocytosis: from recognition to treatment (Tsewang Tashi MD) – (1 hr CE) ACCME ACPE MOC
• Pancreatic Cancer: Updates from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting – (0.75 hr CE) ACCME ACPE MOC
• Metastatic urothelial carcinoma (mUC): Updates from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (Waddah Arafat MD) – (0.75 hr CE) ACCME ACPE MOC
• Taking the next step in the management of relapsed or refractory follicular lymphoma (Eric Tam MD) – (1 hr CE) ACCME ACPE MOC
• Initial- and later-line treatment considerations in advanced renal cell carcinoma (RCC) – (1 hr CE) ACCME ACPE MOC
• Treatment considerations in relapsed or refractory chronic lymphocytic leukemia (R/R CLL): evolving approaches to an evolving disease landscape – (1 hr CE) ACCME ACPE MOC
• Contemporary treatment approaches in the management of chronic graft-versus-host disease (GVHD) – (1 hr CE) ACCME ACPE MOC
• Hitting management strategies of metastatic nasopharyngeal carcinoma on the nose – (1 hr CE) ACCME ACPE MOC
• Advanced hepatocellular carcinoma (HCC) including updates from the European Society for Medical Oncology (ESMO) 2023 – (0.75 hr CE) ACCME ACPE MOC

Target Audience: HCPs including: medical oncologists, oncology surgeons, and pathologists; physicians assistants, nurse practitioners, and pharmacists specializing in oncology, hematology, gastroenterology, urology, with some overlap in otolaryngology, transplant medicine, allergy/immunology, nephrology, and hepatology

The AudioDigest CME + CE + MOC Oncology Platinum Membership is our most comprehensive plan available. Get unlimited access to every lecture in our library across all specialties, including over 4,000 evidence-based audio lessons and written summaries with suggested readings and test questions certified for CME, CE, and MOC credits across 14 specialties.

Activity Description / Statement of Need:

In this online, self-learning activity:

Graft-versus-host disease (GvHD) is an immune-mediated response that occurs in recipients of allogenic hematopoietic cell transplantation (HCT). GvHD can be further categorized into acute and chronic cases. Maculopapular rash, follicular erythema, epidermolysis, are common manifestations of acute GvHD, in addition to liver and gastrointestinal dysfunction such as hyperbilirubinemia, nausea, and diarrhea. This activity focuses on chronic GvHD, which has more extensive multi-organ involvement including the liver, eyes, mouth, lungs, skin, genitalia, and gastrointestinal tract.

Target Audience:

The following HCPs: hematologists and oncologists; nurse practitioners, physician assistants, and pharmacists who specialize in oncology; and those who otherwise commonly care for or clinically encounter patients with GVHD.

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Key Topics in Oncology CME

The Brigham and Dana-Farber Board Review and Comprehensive Update in Oncology is an online CME course designed to update knowledge and improve management strategies. This collection of case-based presentations — presented by a distinguished faculty of experts — will help enhance patient care while you prep for your board exam. It’s continuing medical education that helps you to:

• Apply recommended oncology guidelines in clinical practice
• Perform differential diagnosis of complex oncologic disorders
• Identify and apply current therapeutic options for oncologic disorders
• Evaluate and interpret up-to-date literature relevant to oncology
• Illustrate knowledge of pathophysiology as it applies to management of oncology disorders
• Apply knowledge gained to the ABIM certification/recertification oncology examinations

This program is also available as part of the combined Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology CME course found here.

Activity Description / Statement of Need:
In this online, self-learning activity:

Systemic mastocytosis (SM) is a heterogeneous group of disorders caused by proliferation of abnormal clonal mastocytes, which accumulate in the skin and/or other organ systems. Mastocytosis, including SM, was reclassified as a distinct disease subtype in 2016, when the World Health Organization (WHO) removed mastocytosis from the myeloproliferative neoplasm (MPN) group. The WHO defines 5 SM subtypes, ranging from indolent SM, which is associated with mild symptoms and near-normal life expectancy, to mast cell leukemia, which is an aggressive hematologic malignancy associated with median survival of less than 1 year.

Target Audience:
HCPs including: hematology/oncology specialists, allergists, and clinical immunologists, dermatologists; physician assistants, nurse practitioners, and pharmacists who practice in those areas of specialty; and any other healthcare professionals with an interest in or who may clinically encounter patients with systemic mastocytosis.

Penn Radiology Emergency Imaging After Hours provides insight for imaging conditions where rapid response is required. An elite faculty guides learners with practical lessons in modality choice, image acquisition and interpretation skills for a wide range of clinical presentations. Selected topics in chest, neuroradiology, abdominal, pelvic, pediatric and musculoskeletal imaging are presented to ensure confident analysis, so the practitioner is never outside of their comfort zone. Worth up to 15.75 AMA PRA Category I Credits™, all applicable as SA-CME for Maintenance of Certification requirements.

The Cleveland Clinic Thyroid Expo provides an updated review of the many multidisciplinary guidelines for the treatment of thyroid disorders. An expert faculty addresses topics such as molecular applications in thyroid neoplasia, cancer care, practical management tips and advances in laboratory testing. It focuses on new technologies in thyroid surgery, with a goal of increasing competence and clinical performance in managing routine and complex patient cases.

Worth 5 AMA PRA Category I Credits™, this activity is essential for all physicians, nurses and physician assistants involved in the care of patients with thyroid disease, including those in primary care, endocrinology, surgery, pathology, genetics, immunology and oncology. ANCC and AAPA accreditation also provided with NO POST TEST. Additionally, physicians can earn up to 5 points for ABIM MOC and ABS continuous certification.

Elevate Your Hematology and Oncology CME

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

• Acquired/Congenital Bone Marrow Failure
• Thalassemia/Hemoglobinopathies
• Transfusion Medicine
• New Therapies (Pharmacology)
• Infections of the Immunocompromised
• Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
• Thoracic Oncology (Head/Neck/Lung/Thyroid)
• and many more…

The Cleveland Clinic Multispecialty Pathology Symposium features an expert faculty addressing commonly encountered problems and providing practical tips from their own experience at the microscope. A broad spectrum of cases will be presented, reviewing genitourinary, pulmonary, gastrointestinal and soft tissue, gynecologic, and breast pathology. Participation in this activity will increase knowledge and improve performance in pathology, which will positively impact patient care.

Worth 16.75 AMA PRA Category I Credits™, all applicable towards the Lifelong Learning requirements in the American Board of Pathology (ABPath) Continuing Certification program. NO POST TEST required.

This video activity focuses on ways to help early detection of breast cancer by learning the risk factors, the different screening and diagnostic modalities and guidelines to what kind of screening is needed, and most importantly, when should screening begin.

From October to December, 2022, 50% of the proceeds from this course will be donated to the National Breast Cancer Foundation. Despite the advances in breast cancer detection and treatment, on the psychological side, clinicians who have been involved in the emotional care of cancer patients can report that a breast cancer diagnosis can nevertheless generate many concerns for patients, as well as their families. Psychological interventions for breast cancer patients have well-documented success in reducing distress and enhancing psychosocial adaptation to disease. As such, these interventions have been highlighted as important mechanisms by which physical health can be improved. This activity focuses on the common issues that impact psychological adjustment to breast cancer and interventions that will help optimize care in the cancer context.